Former FDA leaders endorse plasma as a key coronavirus treatment

Published



Four former Food and Drug Administration commissioners said Monday that convalescent plasma therapy has the potential to be the best treatment available for coronavirus patients.

“More work has yet to be done to demonstrate that such a therapy is safe and effective, but if so, it could help millions of patients with the novel coronavirus both here and abroad,” former Commissioners Mark McClellan, Margaret Hamburg, Robert Califf, and Scott Gottlieb wrote in the Washington Post.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.